- $20.60bn
- $20.98bn
- $3.07bn
- 96
- 14
- 67
- 60
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,015 | 2,161 | 2,424 | 2,696 | 3,073 |
Cost of Revenue | |||||
Gross Profit | 1,022 | 1,113 | 1,262 | 1,387 | 1,603 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,748 | 1,785 | 1,977 | 2,202 | 2,490 |
Operating Profit | 267 | 376 | 448 | 493 | 583 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 261 | 363 | 482 | 499 | 586 |
Provision for Income Taxes | |||||
Net Income After Taxes | 203 | 267 | 357 | 369 | 435 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 203 | 267 | 357 | 369 | 435 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 203 | 267 | 357 | 369 | 435 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.49 | 0.543 | 0.677 | 0.749 | 0.896 |
Dividends per Share | |||||
Special Dividends per Share |